Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study

Among cancer patients treated with fluoropyrimidines, 10-40% develop severe toxicity. Polymorphism of the dihydropyrimidine dehydrogenase (<i>DPYD</i>) gene may reduce DPD function, the main enzyme responsible for the metabolism of fluoropyrimidines. This leads to drug accumulation and t...

Full description

Saved in:
Bibliographic Details
Main Authors: Paula Soria-Chacartegui (Author), Gonzalo Villapalos-García (Author), Luis A. López-Fernández (Author), Marcos Navares-Gómez (Author), Gina Mejía-Abril (Author), Francisco Abad-Santos (Author), Pablo Zubiaur (Author)
Format: Book
Published: MDPI AG, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available